News Focus
News Focus
Followers 843
Posts 122806
Boards Moderated 10
Alias Born 09/05/2002

Re: Double_Bagel post# 16810

Tuesday, 02/21/2017 11:02:06 AM

Tuesday, February 21, 2017 11:02:06 AM

Post# of 20689

Craig seemed to hint that the problems were not related to the Glatopa 20mg/40mg production line..

We can go further than that and conclude that the compliance issue is unrelated to Glatopa, else the production/shipment of 20mg Glatopa would be affected. CW said MNTA's general counsel wouldn't let him comment in more detail, but it's very clear that Glatopa is not the cause of this problem.

CW confirmed that 20mg Glatopa and 40mg Glatopa share the same production line, as you noted.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”